EDMONTON, May 9, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company, through its wholly owned subsidiary Aurora Deutschland, has... read more →
SMITHS FALLS, ON, May 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to announce today that has signed an offtake agreement with PharmHouse... read more →
TORONTO, May 8, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX: TGOD) (OTCQX: TGODF) is pleased to announce the Company's strategic investment into the US beverage space as... read more →
Company plans to add 203,000 square feet at three of its existing facilities located in Leamington, Ontario; London, Ontario; and Nanaimo, British Columbia NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (NASDAQ: TLRY),... read more →
VANCOUVER, British Columbia, May 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to provide its shareholders and investors... read more →
Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO, May 07, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”)... read more →
Ignite to capitalize on new UK and European markets with its super premium line of CBD products VAUGHAN, ON, May 7, 2019 /CNW/ - Ignite International Brands, Ltd. (CSE: BILZ) (the... read more →
Twelve SKUs Addressing Demand in Fast-Growing Animal Health CBD Sector BOULDER, CO, May 7, 2019 /CNW/ - (CSE: CWEB, OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web", or the "Company") the market share... read more →
SMITHS FALLS, ON, May 7, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all... read more →
- Epidiolex U.S. Q1 net sales of $33.5m - - Positive Phase 3 pivotal results in Tuberous Sclerosis Complex, sNDA submission expected in Q4 2019 - - Conference call today... read more →
